When Does Semaglutide Start Suppressing Appetite — and What to Expect Week by Week

Appetite suppression typically starts within days to two weeks at the 0.25mg starting dose, but most people notice a stronger effect as the dose increases toward maintenance.
The mechanism works through two routes: slower stomach emptying (so food stays with you longer) and direct signalling in appetite-regulating parts of the brain.
Some people notice very little change at the starting dose, that is expected and not a sign the treatment is failing.
The pace of appetite change is individual; factors including your current dose, how long you have been on it, and what you eat all play a role.

Semaglutide begins suppressing appetite within the first one to two weeks of starting treatment for most people, though the full effect builds gradually over several months as the dose increases. The appetite-reducing action comes from semaglutide's work on GLP-1 receptors in the brain and gut — slowing gastric emptying, reducing hunger signals and increasing feelings of fullness after smaller meals. These are prescription-only medicines: a GPhC-registered prescriber assesses whether Wegovy is clinically suitable for you before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How appetite suppression develops on semaglutide, a week-by-week picture

Step 1: The first two weeks, early signals, modest changes

The 0.25mg starting dose is there to let your body adjust, not to deliver maximum effect. Even so, many people notice something in the first week or two: meals that used to finish without a second thought now feel like enough partway through, or the mid-morning snack craving simply doesn't arrive. The NHS medicines page for semaglutide describes the mechanism clearly, it activates GLP-1 receptors that slow how quickly the stomach empties and that communicate directly with appetite centres in the brain.

Not everyone feels this at 0.25mg. If you reach the end of the first month and think nothing has changed, that is completely normal. The starting dose is a tolerability measure, and the meaningful appetite shift usually comes later. Some people find the nausea they experience in week one is the only obvious signal that something is happening at all, the hunger reduction follows.

It can feel frustrating to be a few weeks in with no clear result, and if you want a clearer sense of the expected timeline, our page on when appetite suppression typically starts with semaglutide explains what to look out for at each stage. That frustration is understandable, and it is worth knowing the dose trajectory is deliberate, the treatment is designed to build, not to hit hard at the start.

Step 2: Weeks four to sixteen, dose increases and the appetite curve

Each four-week step up the titration schedule (0.25mg to 0.5mg, then 1.0mg, then 1.7mg) tends to bring a more noticeable reduction in appetite than the previous one. This is the phase most people describe as the real shift: portions shrink naturally, feelings of hunger between meals fade, and high-calorie foods that used to be hard to resist become easier to leave. Gastric emptying slows further with each dose increase, so meals physically take longer to digest, which extends the sensation of fullness.

This is also the phase where what you eat starts to matter more than it did before, because appetite suppression works best alongside a reduced-calorie diet. Our guide to what to eat on Wegovy covers practical food choices that support the treatment without making you feel deprived. Protein, fibre and hydration become especially relevant here, the prescriber and any dietitian you work with are the right people to shape a personal plan.

Side effects during dose increases are typically gastrointestinal: nausea, indigestion, loose stools. They are most common in the days after a step-up and usually settle within a week or two. The STEP 1 trial, published in the New England Journal of Medicine, showed an average weight reduction of around 15% over 68 weeks at 2.4mg, evidence that the appetite suppression is meaningful and sustained at maintenance dose.

Step 3: Reaching 2.4mg maintenance, what sustained appetite suppression looks like

At 2.4mg, the licensed maintenance dose of Wegovy, appetite suppression reaches its most consistent level. For most people on Wegovy, this means eating less without a constant effort of willpower, hunger arrives less frequently and passes more quickly when it does. Cravings for very rich or fatty food also tend to reduce, partly because gastric emptying remains slowed and partly through central appetite pathways.

The MHRA approved a higher 7.2mg maintenance dose in January 2026, with trials reporting around 20.7% average weight loss at that level. Whether a higher dose is appropriate is a clinical decision, something a prescriber discusses based on how you have responded so far. If you feel Wegovy's appetite effect has faded or stopped working at your current dose, it is worth reading more about what to do when Wegovy no longer suppresses appetite before drawing conclusions; there are several reasons this can happen, and most are addressable.

A note on realistic expectations: semaglutide suppresses appetite, it does not eliminate it. Hunger will still arrive, it simply arrives less insistently, and fullness comes sooner. That is the mechanism, and it works best when paired with the lifestyle changes your prescriber supports you with throughout treatment.

What affects how quickly the appetite suppression kicks in?

The timing varies between individuals, and several factors influence it. People who are very sensitive to GLP-1 effects sometimes notice appetite changes within days of the first injection. Others, particularly at the lower starting doses, notice very little until the second or third titration step. Current dose, time on treatment and individual physiology all play a part.

If you are considering Wegovy or have just started and want a clearer sense of what the treatment involves, the Wegovy overview page covers the full picture, from how it works to eligibility and what private access involves. For those wondering whether appetite suppression is actually happening when it feels subtle, our page on how Wegovy suppresses appetite goes into the mechanism in more depth.

If you are already on treatment and feel the appetite effect has disappeared, that is a different concern worth discussing with a prescriber. Our page on Wegovy not suppressing appetite covers the common reasons and what can be done. The right support during treatment makes a real difference, and if you have not yet started, speaking to our prescribers is a sensible first step before comparing doses and timelines in the abstract.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions